Lyme Disease Vaccine (Recombinant OspA) - LYMErix; recombinant Borrelia burgdorferi outer surface protein A (OspA) -- Product Record

Lyme Vaccine, rDNA/GSK

    Nomenclature:
      Lyme Vaccine, rDNA/GSK [BIO]
      Lyme Disease Vaccine (Recombinant OspA) [FDA]
      LYMErix [TR]
      Borrelia burgdorfi outer surface protein A (OspA), recombinant [SY]
      L-OspA with aluminum hydryoxide adjuvant [SY]
      Lyme Vaccine, recombinant [SY]

    molecular weight (kDa) = 27.8

    FDA Class:  Biologic BLA

    Year of approval (FDA) = 1998

Index Terms: